Search
"Infusion reaction during a docetaxel infusion, followed by an atypical, delayed vesicant-type reaction, without a clear extravasation history" Su et al (2020).
Abstract:

Docetaxel is an anti-neoplastic agent commonly used to treat major solid tumors. Common toxicities of docetaxel include neutropenia, alopecia, nausea and vomiting. While docetaxel is typically considered an irritant, we present the case report of a 54-year-old female with high-grade undifferentiated uterine sarcoma who experienced a standard infusion reaction during a docetaxel infusion, followed by an atypical, delayed vesicant-type reaction, without a clear extravasation history.

Reference:

Su J, Bernard L, Colantonio S, Norgaard A, Hirte HW, Eiriksson L. Bullous vesicant-type reaction to docetaxel along the venous tract: A case report. Gynecol Oncol Rep. 2020 Sep 11;34:100640. doi: 10.1016/j.gore.2020.100640. PMID: 33005719; PMCID: PMC7519356.